Simplex Trading’s Aevi Genomic Medicine Inc GNMX Stock Holding History
Bought
Maintained
Sold
Simplex Trading's GNMX Position: Q1 2020 in Review
Simplex Trading sold out of Aevi Genomic Medicine Inc (GNMX) in Q1 2020, closing a stake of 100 shares.
Simplex Trading first reported a position in GNMX in Q4 2014 and held it in 12 quarters. The position peaked at $15K in Q4 2015. 2 funds tracked by Wall St. Rank hold GNMX as of Q1 2020.
- Simplex Trading reported no remaining Aevi Genomic Medicine Inc position as of Q1 2020 after selling out during the quarter.
- Simplex Trading sold 100 Aevi Genomic Medicine Inc shares in Q1 2020.
- Simplex Trading first reported a position in Aevi Genomic Medicine Inc in Q4 2014 and held it in 12 quarters.
- Simplex Trading's Aevi Genomic Medicine Inc position peaked at $15K in Q4 2015.
- 2 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q1 2020.
Based on Simplex Trading's 13F filing for Q1 2020, filed 29 Apr 2020.